Miscarriage risk from amniocentesis performed for abnormal maternal serum screening
- 1 June 2007
- journal article
- conference paper
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 196 (6) , 608.e1-608.e5
- https://doi.org/10.1016/j.ajog.2007.03.010
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Diagnostic mid trimester amniocentesis: How safe?American Journal of Obstetrics and Gynecology, 2004
- Pregnancy loss rates after midtrimester amniocentesis: the faster trialAmerican Journal of Obstetrics and Gynecology, 2003
- Spontaneous fetal loss rates in a non-selected populationAmerican Journal of Medical Genetics, 2001
- Choriodecidual inflammatory syndrome (CoDIS) is the leading, and under recognised, cause of early preterm delivery and second trimester miscarriageMedical Hypotheses, 2001
- Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcomePublished by Wolters Kluwer Health ,2001
- Pregnancy outcome following genetic amniocentesis at 11–14 versus 16–19 weeks' gestationPublished by Wolters Kluwer Health ,1999
- Elevated amniotic fluid interleukin-6 levels at genetic amniocentesis predict subsequent pregnancy lossAmerican Journal of Obstetrics and Gynecology, 1996
- Prostaglandins: Cause or consequence of labor?American Journal of Obstetrics and Gynecology, 1995
- RANDOMISED CONTROLLED TRIAL OF GENETIC AMNIOCENTESIS IN 4606 LOW-RISK WOMENPublished by Elsevier ,1986
- Prenatal Genetic Diagnosis in 3000 AmniocentesesNew England Journal of Medicine, 1979